2.50
Hdl Handle:
http://hdl.handle.net/10755/203271
Type:
Presentation
Title:
Amiodarone Induced Thrombophlebitis
Abstract:
(Summer Institute) Intravenous Amiodarone has been frequently used for severe arrhythmias. When used through a peripheral IV, there has been a high incidence of thrombophlebitis. Thrombophelibitis is the most common complication of peripherally infused Amiodarone even with the use of a filter. The purpose of the project is to develop ways to reduce the incidence of amiodarone induced thrombophlebitis when amiodarone is used for extended treatment of arrhythmia. A sample of approximately 40 post-operative patients that developed atrial fibrillation, was observed. The groups were split into peripherial IV catheter and central venous catheter. Approximately 15 of the 20 developed thrombophlebitis when amiodarone was infused through a peripheral IV for more than 48 hours. The 20 that received it the drug through the central venous catheter did not develop thrombophlebitis. Reduction in amiodarone-induced thrombophlebitis will reduce healthcare costs and length of stay from complications. [© Academic Center for Evidence-Based Practice, 2011. http://www.acestar.uthscsa.edu]
Keywords:
Amiodarone; Thrombophlebitis
Repository Posting Date:
16-Jan-2012
Date of Publication:
3-Jan-2012
Sponsors:
UTHSCSA Summer Institute

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleAmiodarone Induced Thrombophlebitisen_GB
dc.identifier.urihttp://hdl.handle.net/10755/203271-
dc.description.abstract(Summer Institute) Intravenous Amiodarone has been frequently used for severe arrhythmias. When used through a peripheral IV, there has been a high incidence of thrombophlebitis. Thrombophelibitis is the most common complication of peripherally infused Amiodarone even with the use of a filter. The purpose of the project is to develop ways to reduce the incidence of amiodarone induced thrombophlebitis when amiodarone is used for extended treatment of arrhythmia. A sample of approximately 40 post-operative patients that developed atrial fibrillation, was observed. The groups were split into peripherial IV catheter and central venous catheter. Approximately 15 of the 20 developed thrombophlebitis when amiodarone was infused through a peripheral IV for more than 48 hours. The 20 that received it the drug through the central venous catheter did not develop thrombophlebitis. Reduction in amiodarone-induced thrombophlebitis will reduce healthcare costs and length of stay from complications. [© Academic Center for Evidence-Based Practice, 2011. http://www.acestar.uthscsa.edu]en_GB
dc.subjectAmiodaroneen_GB
dc.subjectThrombophlebitisen_GB
dc.date.available2012-01-16T11:07:04Z-
dc.date.issued2012-01-03en_GB
dc.date.accessioned2012-01-16T11:07:04Z-
dc.description.sponsorshipUTHSCSA Summer Instituteen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.